Bank Of Montreal Sio Gene Therapies Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.25 - $0.73 $2,500 - $7,300	-10,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.55 - $1.47 $5,500 - $14,700	10,000 New	10,000 $7,000
Q4 2021 Feb 11, 2022	SELL	$1.29 - $2.36 $566,190 - $1.04 Million	-438,907 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.81 - $2.7 $794,421 - $1.19 Million	438,907 New	438,907 $935,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.